Medpace Holdings up on beating Q3 estimates

Medpace Holdings

24/10/2022 22:13

** Biopharmaceutical firm Medpace Holdings Inc's shares
 MEDP.O  rise 20.6% to $189.5 after market
    ** MEDP's Q3 revenue of $383.7 mln surges past analysts
estimate of $357.2 mln -Refinitiv IBES data
    ** MEDP reports profit of $2.05 per share compared to
analyst estimate of $1.47 per share - Refinitiv IBES
    ** Co expects to post 2022 revenue in range of $1.44 bln to
$1.46 bln more than analyst estimate of $1.41 bln - Refinitiv
IBES data
    ** As of last close, stock had fallen ~27% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))